Inari Medical Inc (NAS:NARI)
$ 49.885 0.605 (1.23%) Market Cap: 2.90 Bil Enterprise Value: 2.80 Bil PE Ratio: 0 PB Ratio: 6.47 GF Score: 76/100

Inari Medical Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 02:40PM GMT
Release Date Price: $67.59 (+2.52%)
Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate

Perfect. Thank you, everyone. I'm Kallum Titchmarsh, medical device analyst here at Morgan Stanley. Delighted today to be joined with the Inari Medical team. We've got Drew Hykes, CEO; Mitch Hill, CFO; and Tom Tu, CMO. Gents, thank you so much for joining.

Before I get started, I need to read you the research disclosures. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Questions & Answers

Kallum L Titchmarsh;Andrew J. Hykes
Morgan Stanley, Research Division - Research Associate;Inari Medical, Inc. - CEO, President

So just wanted to start, Drew, curious to hear what's occupying your time now, 9 months as CEO. How has that changed from the start to where we're at this point?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot